Cosmos Health Dirección

Dirección controles de criterios 3/4

El CEO de Cosmos Health's es Greg Siokas, nombrado en Feb 2016, tiene una permanencia de 8.33 años. posee directamente un 8.28% de las acciones de la empresa, con un valor de $974.82K. La antigüedad media del equipo directivo y de la junta directiva es de 6 años y 5.4 años, respectivamente.

Información clave

Greg Siokas

Chief Executive Officer (CEO)

US$600.0k

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	8.3yrs
Participación del CEO	8.3%
Permanencia media de la dirección	6yrs
Promedio de permanencia en la Junta Directiva	5.4yrs

Actualizaciones recientes de la dirección

Recent updates

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

Feb 23

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Jul 20

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Jul 06

CEO

Greg Siokas (59 yo)

8.3yrs

Permanencia

US$600,000

Compensación

Mr. Grigorios Siokas, also known as Greg, has been the Chairman and Chief Executive Officer of Cosmos Health Inc. (formerly known as Cosmos Holdings Inc.) since February 26, 2016 and served as its Presiden...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Grigorios Siokas	Chairman & CEO	8.3yrs	US$600.00k	8.28% $ 946.9k
Georgios Terzis	Chief Financial Officer	3.6yrs	US$108.12k	0.91% $ 103.5k
Demetrios Demetriades	Secretary & Independent Director	10.4yrs	US$10.00k	0.030% $ 3.4k
Nikolaos Bardakis	Chief Operating Officer	1.3yrs	sin datos	0.059% $ 6.8k

6.0yrs

Permanencia media

56.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de COSM es experimentado (6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Grigorios Siokas	Chairman & CEO	8.3yrs	US$600.00k	8.28% $ 946.9k
Demetrios Demetriades	Secretary & Independent Director	10.4yrs	US$10.00k	0.030% $ 3.4k
Manfred Ziegler	Independent Director & Member of Advisory Board	1.5yrs	US$10.00k	0.030% $ 3.4k
Anastasios Tzikas	Member of Advisory Board	5.6yrs	sin datos	sin datos
Anastasios Aslidis	Independent Director	2.2yrs	US$62.50k	0.12% $ 13.6k
Athanasios Kolefas	Member of Advisory Board	5.4yrs	sin datos	1.27% $ 145.8k
Alexios Papaconstantinou	Member of Advisory Board	2.9yrs	sin datos	sin datos
John Hoidas	Independent Director	7.6yrs	US$10.00k	0.030% $ 3.4k
Orestes Varvitsiotes	Member of Advisory Board	7.4yrs	sin datos	sin datos
Panagiotis Zoumpoulakis	Member of Advisory Board	1.9yrs	sin datos	sin datos
Suhel Bhutawala	Director	less than a year	sin datos	0.030% $ 3.4k

5.4yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de COSM se considera experimentada (5.4 años de antigüedad promedio).

Cosmos Health Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

High number of new and inexperienced directors

High number of new and inexperienced directors

Cosmos Health Inc. Announces Executive and Board Changes

Cosmos Health Inc., Annual General Meeting, Sep 18, 2023

Cosmos Health Inc. Appoints Nikos Bardakis as Chief Operating Officer

Chairman & CEO exercised options to buy US$605k worth of stock.

Recent updates

Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of its Forms 10-K and 10-Q

Cosmos Health Inc. announced delayed 10-Q filing

Cosmos Health Inc. announced delayed annual 10-K filing

Cosmos Health Inc. Receives Non-Compliance Letter from Nasdaq Related to Minimum Bid Price

Cosmos Health Inc. Commences Development of Cloudscreen 2.0 the New Iteration of Its Next Generation AI Drug Repurposing Platform

Cosmos Health Inc. Receives Regulatory Approval to Sell Sky Premium Life Products in UAE Nutritional Supplements Market

New major risk - Financial position

Cosmos Health Inc. has filed a Follow-on Equity Offering in the amount of $5.049535 million.

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

High number of new and inexperienced directors

Cosmos Health Inc. (NasdaqCM:COSM) completed the acquisition of Cloudscreen.

Cosmos Health Inc. announced delayed 10-Q filing

High number of new and inexperienced directors

Cosmos Health Inc. (NasdaqCM:COSM) signed an agreement to acquire Cloudscreen.

Cosmos Health Inc. Announces Executive and Board Changes

Cosmos Health Inc. Provides Earnings Guidance for the Year 2023

Cosmos Health Inc., Annual General Meeting, Sep 18, 2023

Cosmos Health Inc. announced delayed 10-Q filing

Second quarter 2023 earnings released: US$0.091 loss per share (vs US$23.37 loss in 2Q 2022)

Cosmos Health Inc. announced that it has received $5.25 million in funding

Cosmos Holdings Inc. (NasdaqCM:COSM) acquired 100% stakes in Cana Laboratories S.A. for approximately $1.67 million.

Cosmos Health Inc. Launches Terra Creta

Cosmos Health Inc. entered into letter of intent agreement to acquire Docpharm Arzneimittelvertrieb Gmbh & Co. Kg Auf Aktien.

Cosmos Health Inc. announced delayed 10-Q filing

Full year 2022 earnings released: US$33.16 loss per share (vs US$23.74 loss in FY 2021)

Cosmos Health Inc. Appoints Nikos Bardakis as Chief Operating Officer

Cosmos Health Inc. (NasdaqCM:COSM) announces an Equity Buyback for $3 million worth of its shares.

Cosmos Health Inc. announced that it has received $32.52568 million in funding

Cosmos Health Inc. announced that it has received $32.52568 million in funding

Cosmos Health Inc. has completed a Follow-on Equity Offering in the amount of $32.52568 million.

Cosmos Health Inc. has completed a Follow-on Equity Offering in the amount of $32.52568 million.

Chairman & CEO exercised options to buy US$605k worth of stock.

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Third quarter 2022 earnings released: US$0.077 loss per share (vs US$0.11 loss in 3Q 2021)

Cosmos Holdings Inc., Annual General Meeting, Dec 02, 2022

Cosmos Holdings Inc. has completed a Follow-on Equity Offering in the amount of $7.5 million.

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into a non-binding letter of intent agreement to acquire ZipDoctor, Inc from American International Holdings Corp. (OTCPK:AMIH).

Cosmos Holdings intends to acquire telemedicine platform ZipDoctor

Cosmos Holdings reports Q2 results

Cosmos Holdings Inc. announced delayed 10-Q filing

Cosmos Holdings Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price

Cosmos changes name to Cosmos Healthto

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into a binding letter of intent to acquire Cana Laboratories S.A.

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Cosmos Holdings, Inc. Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

Cosmos Holdings Inc. (NasdaqCM:COSM) entered into an agreement to acquire product portfolio of Life NLB, Ltd.

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Cosmos Holdings Inc. announced delayed 10-Q filing

Cosmos Holdings Inc. announced delayed annual 10-K filing

Cosmos Holdings Inc. announced delayed annual 10-K filing

Cosmos Holdings, Inc. Launches Osteodome in EU

Cosmos Holdings Inc. Launches New Proprietary Enhanced Dietary Supplement

Cosmos Holdings Inc. Appoints Georgios Terzis as Chief Financial Officer

Cosmos Holdings Inc. Announces David Lowenstein Agrees to Join Cosmos Board of Directors

Cosmos Holdings Inc. Announces Executive Changes

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad